Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PetVivo | PETV | Apr 25, 2024 | 1.04 | 0.00 |
Pfizer | PFE | Apr 25, 2024 | 25.26 | -3.84 |
Pgim Global High Yield Fund | GHY | Apr 25, 2024 | 11.38 | -0.35 |
Pgim High Yield Bond Fund | ISD | Apr 25, 2024 | 12.36 | -0.96 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Apr 25, 2024 | 14.97 | -0.80 |
PGT Innovations | PGTI | Apr 25, 2024 | 41.99 | 0.00 |
Pharmaceutical ETF Market Vectors | PPH | Apr 25, 2024 | 86.52 | +0.17 |
PharmaCyte Biotech | PMCB | Apr 25, 2024 | 2.12 | -3.64 |
Pharming Group ADR | PHAR | Apr 25, 2024 | 10.45 | +6.31 |
Pharvaris | PHVS | Apr 25, 2024 | 22.77 | +7.15 |
Phathom Pharmaceuticals | PHAT | Apr 25, 2024 | 9.10 | -0.22 |
PhenixFIN | PFX | Apr 25, 2024 | 44.18 | -1.61 |
Phibro Animal Health A | PAHC | Apr 25, 2024 | 12.44 | -0.96 |
Philip Morris | PM | Apr 25, 2024 | 96.09 | -2.96 |
Philippines Invstb Mkt Idx MSCI Ishares | EPHE | Apr 25, 2024 | 25.21 | 0.00 |
Phillips 66 | PSX | Apr 25, 2024 | 157.24 | -0.35 |
Phillips Edison & Company | PECO | Apr 25, 2024 | 32.93 | -0.90 |
PHINIA | PHIN | Apr 25, 2024 | 38.32 | -1.06 |
Phio Pharmaceuticals | PHIO | Apr 25, 2024 | 0.71 | +5.22 |
PHLX Semiconductor | SOX | Apr 25, 2024 | 4 615.04 | +1.96 |
PHLX Sox Semiconductor Sector Ishares | SOXX | Apr 25, 2024 | 212.41 | +1.86 |
Phoenix Biotech Acquisition Unit | PBAXU | Apr 25, 2024 | 10.37 | 0.00 |
Phoenix Motor | PEV | Apr 25, 2024 | 0.60 | -3.49 |
Phoenix New Media A ADR | FENG | Apr 25, 2024 | 1.78 | +1.14 |
Photronics | PLAB | Apr 25, 2024 | 27.76 | +0.91 |
PHP Ventures Acquisition A | PPHP | Apr 25, 2024 | 11.07 | 0.00 |
Phreesia | PHR | Apr 25, 2024 | 20.46 | -6.75 |
Phunware | PHUN | Apr 25, 2024 | 6.14 | -2.23 |
PHX Minerals | PHX | Apr 25, 2024 | 3.46 | -1.98 |
Physical Palladium | PALL | Apr 25, 2024 | 90.29 | -2.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.